The Role Played by Clay Siegall in Cancer Research and Mitigation

Cancer is the one modern day sickness whose cure has eluded the medical community for many decades now. The best trials that have been done are radiotherapy and chemotherapy and this only works when cancer has not reached certain advanced stages. Scientists such as Clay Siegall have been researching on treatments that can deal with cancer once and for all and have confidence that their clinical trials are heading somewhere. Clay co-founded a clinical trials company known as Seattle Genetics in 1998. In the past twenty years, the company has been developing cures and treatment options for different types of tumors.

About two years ago, Siegall got his big break when the FDA approved one of the drugs he had been developing. The drug has since been adopted for use in treating different types of lymphomas in 66 countries. Also, Seattle Genetics is trading their shares on NASDAQ under the name SGEN. They have reported more than half a million dollars in drug sales since they started selling.

Clay states that things were not always as easy as they seem now. He confides that there were times when they were so strapped for cash that they couldn’t even afford a salary for their employees. The hard work and resilience have significantly paid off because now the company is selling their drugs abroad, and their chief marketer in Canada is Takeda Pharmaceuticals.

Clay states that the main aim of the research they are carrying out and the drugs they are creating is to build better outcomes by giving the patient strong antibody conjugates and directing them to the specific tumor cells. He adds that besides the one drug that has been approved, there are 11 others which are in different trial stages. He hopes that they will manage to get the drugs approved as well. To speed up the process of testing the drugs, they have expanded their capacity and hired more researchers to help with the process. Clay hopes that they will have an easy time dealing with FDA this time around and that their drugs will be a game changer in cancer treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *